Referanser

Agustsson, T. T., Baldvinsdottir, T., Jonasson, J. G., Olafsdottir, E., Steinthorsdottir, V., Sigurdsson, G., ... Benediktsson, R. (2015). The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. European Journal of Endocrinology of the European Federation of Endocrine Societies, 173(5), 655-64.

Ajithkumar, T., & Brada, M. (2004). Stereotactic linear accelerator radiotherapy for pituitary tumors. Treatments in Endocrinology, 3(4), 211-6.

Becker, G., Kocher, M., Kortmann, R. D., Paulsen, F., Jeremic, B., Müller, R. P., & Bamberg, M. (2002). Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 178(4), 173-86.

Bengtsson, D., Schrøder, H. D., Andersen, M., Maiter, D., Berinder, K., Feldt Rasmussen, U., ... Burman, P. (2015). Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. Journal of Clinical Endocrinology and Metabolism, 100(4), 1689-98.

Brada, M., Burchell, L., Ashley, S., & Traish, D. (1999). The incidence of cerebrovascular accidents in patients with pituitary adenoma. International Journal of Radiation Oncology, Biology, Physics, 45(3), 693-8.

Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., ... Karlsson, F. A. (2013). Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. Journal of Clinical Endocrinology and Metabolism, 98(4), 1466-75.

Burman, P., Casar-Borota, O., Perez-Rivas, L. G., & Dekkers, O. M. (2023). Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment. The Journal of Clinical Endocrinology & Metabolism, 108(7), 1585-1601.

Daly, A. F., & Beckers, A. (2015). Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocrinology and Metabolism Clinics of North America, 44(1), 19-25.

Dekkers, O. M., Pereira, A. M., & Romijn, J. A. (2008). Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. Journal of Clinical Endocrinology and Metabolism, 93(10), 3717-26.

Ding, D., Starke, R. M., & Sheehan, J. P. (2014). Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy. Journal of Neuro-Oncology, 117(3), 445-57.

DSA (Under publisering 2023). Faglige anbefalinger for toleransegrenser til risikoorganer i CNS Østerås: Direktoratet for strålevern og atomsikkerhet.

Eaton, D. J., Lee, J., Patel, R., Millin, A. E., Paddick, I., & Walker, C. (2018). Stereotactic radiosurgery for benign brain tumors: Results of multicenter benchmark planning studies. Practical Radiation Oncology, 8(5), e295-e304.

Erridge, S. C., Conkey, D. S., Stockton, D., Strachan, M. W., Statham, P. F., Whittle, I. R., ... Gregor, A. (2009). Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiotherapy and Oncology, 93(3), 597-601.

Freda, P. U., Wardlaw, S. L., & Post, K. D. (1996). Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. Journal of Clinical Endocrinology and Metabolism, 81(10), 3455-9.

Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L. (2011). Pituitary incidentaloma: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96(4), 894-904.

Frieze, T. W., Mong, D. P., & Koops, M. K. (2002). "Hook effect" in prolactinomas: case report and review of literature. Endocrine Practice, 8(4), 296-303.

Gillett, D., Senanayake, R., MacFarlane, J., van der Meulen, M., Koulouri, O., Powlson, A. S., ... Gurnell, M. (2022). Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction. EJNMMI research, 12(1), 26.

Gnanalingham, K. K., Bhattacharjee, S., Pennington, R., Ng, J., & Mendoza, N. (2005). The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. Journal of Neurology, Neurosurgery and Psychiatry, 76(3), 415-9.

Gravdahl, G. B., Tronvik, E. A., Fougner, S. L., & Solheim, O. (2016). Pituitary Adenoma and Non-acute Headache: Is There an Association, and Does Treatment Help?. World Neurosurgery, 92, 284-291.

Helse- og omsorgsdepartementet (2006). Nasjonal strategi for kreftområdet 2006-2009 Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/no/dokumenter/nasjonal-strategi-for-kreftomradet/id446845/

Helse- og omsorgsdepartementet (2006). Nasjonal helseplan (2007–2010) (Særtrykk av St.prp. nr. 1 (2006–2007) kapittel 6). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/globalassets/upload/hod/sykehus/nasjonal_helseplan_sartrykk.pdf

Helse- og omsorgsdepartementet (2013). Sammen - mot kreft: nasjonal kreftstrategi 2013-2017 Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/no/dokumenter/sammen---mot-kreft/id728818/

Helse- og omsorgsdepartementet (2018). Leve med kreft: nasjonal kreftstrategi (2018–2022) Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/no/dokumenter/leve-med-kreft/id2598282/

Hurel, S. J., Thompson, C. J., Watson, M. J., Harris, M. M., Baylis, P. H., & Kendall-Taylor, P. (1996). The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology, 44(2), 141-6.

Jørgensen, A. P., Tazmini, K., red. (8. april 2020). Nasjonal veileder i endokrinologi. [nettdokument]. Oslo: Norsk Endokrinologisk Forening. Hentet 8. juni 2020 fra https://www.endokrinologi.no/

Kaltsas, G. A., Evanson, J., Chrisoulidou, A., & Grossman, A. B. (2008). The diagnosis and management of parasellar tumours of the pituitary. Endocrine-Related Cancer, 15(4), 885-903.

Kong, D. S., Lee, J. I., Lim, D. H., Kim, K. W., Shin, H. J., Nam, D. H., ... Kim, J. H. (2007). The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer, 110(4), 854-60.

Kontogeorgos, G. (2005). Classification and pathology of pituitary tumors. Endocrine, 28(1), 27-35.

Landberg, T., Chavaudra, J., Dobbs, J., Hanks, G., Johansson, K., Möller, T., & Purdy, J. (1993). Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy. Journal of the ICRU, os26(1)

Landberg, T., Chavaudra, J., Dobbs, J., Gerard, J. P., Hanks, G., Horiot, J. C., ... Svensson, H. (1999). Report 62: prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU report 50). Journal of the ICRU, os32(1)

Levernes, S. (2012). Volum og doser i ekstern stråleterapi: definisjoner og anbefalinger (StrålevernRapport 2012:9). Østerås: Statens strålevern. Hentet fra https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/bee8860b-36d1-42e7-8d64-f5ad4fcef2e8:8ebb86decddc2818ec31e4999d26cdf7aec14ac2/StralevernRapport_09-2012.pdf

Levernes, S. (2019). Faglige anbefalinger for nomenklatur for volumer i stråleterapi (Teknisk dokument 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra https://dsa.no/publikasjoner/_/attachment/download/9d2a42a5-241e-4299-86cf-6b02a0abf3b9:2400dff7cb71f4bff583473d690fcb79650dd59e/TekniskDokument14_rev2020.pdf

Loeffler, J. S., & Shih, H. A. (2011). Radiation therapy in the management of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 96(7), 1992-2003.

Lov om kommunale helse- og omsorgstjenester m.m. (helse- og omsorgstjenesteloven). (2011). Sist endret i LOV-2019-06-21-45 fra 01.01.2020. Hentet fra https://lovdata.no/dokument/NL/lov/2011-06-24-30

Magge, R. (2019-2022). Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas (TMZ-Cap) [pågående studie]. (NCT03930771). Hentet fra https://www.clinicaltrials.gov/study/NCT03930771

Marienhagen, K., Djupvik, L. H., Danielsen, T. (2020). Faglige anbefalinger for inntegning av risikoorganer i CNS (Teknisk dokument 16). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra https://dsa.no/publikasjoner/_/attachment/download/401a60b3-b7db-4c4a-b741-da0a70c43b20:f0c3325a0ec4a43b2335cf17df266e4e7c34408c/Teknisk%20dokument16_rev.pdf

Mathieu, D., Kotecha, R., Sahgal, A., De Salles, A., Fariselli, L., Pollock, B. E., ... Sheehan, J. P. (2022). Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations. Journal of Neuro-Oncology, 136(3), 801-812.

Miermeister, C. P., Petersenn, S., Buchfelder, M., Fahlbusch, R., Lüdecke, D. K., Hölsken, A., ... Buslei, R. (2015). Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications. Acta neuropathologica communications, 3, 50.

Minniti, G., Gilbert, D. C., & Brada, M. (2009). Modern techniques for pituitary radiotherapy. Reviews in Endocrine & Metabolic Disorders, 10(2), 135-44.

Minniti, G., Clarke, E., Scaringi, C., & Enrici, R. M. (2016). Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 21(4), 370-8.

Minniti, G., Osti, M. F., & Niyazi, M. (2016). Target delineation and optimal radiosurgical dose for pituitary tumors. Radiation Oncology (London, England), 11(1), 135.

Minniti, G., Flickinger, J., Tolu, B., & Paolini, S. (2018). Management of nonfunctioning pituitary tumors: radiotherapy. Pituitary, 21(2), 154-161.

Molitch, M. E. (2008). Nonfunctioning Pituitary Tumors and Pituitary Incidentalomas. Endocrinology and Metabolism Clinics of North America, 37(1), 151-171.

Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011). Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96(6), 1587-609.

Müller, H. L., Merchant, T. E., Puget, S., & Martinez-Barbera, J. P. (2017). New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nature Reviews: Endocrinology, 13(5), 299-312.

Murad, M. H., Fernández-Balsells, M. M., Barwise, A., Gallegos-Orozco, J. F., Paul, A., Lane, M. A., ... Montori, V. M. (2010). Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clinical Endocrinology, 73(6), 777-91.

Raappana, A., Koivukangas, J., Ebeling, T., & Pirilä, T. (2010). Incidence of pituitary adenomas in Northern Finland in 1992-2007. Journal of Clinical Endocrinology and Metabolism, 95(9), 4268-75.

Raverot, G., Burman, P., McCormack, A., Heaney, A., Petersenn, S., Popovic, V., ... Dekkers, O. M. (2018). European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. European Journal of Endocrinology of the European Federation of Endocrine Societies, 178(1), G1-G24.

Report 78: Prescribing, Recording, and Reporting Proton-Beam Therapy. (2007). Journal of the ICRU, 7(7)

Report 83: Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT). (2010). Journal of the ICRU, 10(1)

Sheehan, J. P., Pouratian, N., Steiner, L., Laws, E. R., & Vance, M. L. (2011). Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. Journal of Neuro-Oncology, 114(2), 303-9.

Sheehan, J. P., Starke, R. M., Mathieu, D., Young, B., Sneed, P. K., Chiang, V. L., ... Lunsford, L. D. (2013). Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. Journal of Neuro-Oncology, 119(2), 446-56.

Tjörnstrand, A., Gunnarsson, K., Evert, M., Holmberg, E., Ragnarsson, O., Rosén, T., & Filipsson Nyström, H. (2014). The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. European Journal of Endocrinology of the European Federation of Endocrine Societies, 171(4), 519-26.

Tjörnstrand, A., Casar-Borota, O., Heurling, K., Schöll, M., Gjertsson, P., Ragnarsson, O., & Filipsson Nyström, H. (2021). Pre- and postoperative (68) Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours. Clinical Endocrinology, 94(6), 956-967.

van Westrhenen, A., Muskens, I. S., Verhoeff, J. J. C., Smith, T. R. S., & Broekman, M. L. D. (2017). Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review. Journal of Neuro-Oncology, 135(1), 1-11.

Watanabe, G., Choi, S. Y., & Adamson, D. C. (2022). Pituitary Incidentalomas in the United States: A National Database Estimate. World Neurosurgery, 158, e843-e855.

WHO Classification of Tumours Editorial Board (2022). Endocrine and neuroendocrine tumours (5 utg.) Lyon: IARC Press.